Submitted on Saturday 31st August 2019
Rejected on Friday 6th September 2019
Current status: Rejected
Rejection code: duplicate (see below for details)
Ensure UK cancer patients retain access to the latest treatments after Brexit
The European Commission has made it clear it would see a post-brexit UK as falling outside EU regulations on clinical trials and the licensing of new medications. This could cause significant delay, or even prevent, cancer patients receiving essential life extending medications following a no-deal.
You can't sign this petition because it was rejected. But you can still comment on it here at Repetition.me!
The Government e-Petitions Team gave the following reason:
There's already a petition about this issue. We cannot accept a new petition when we already have one about a very similar issue.
You are more likely to get action on this issue if you sign and share a single petition.
petition.parliament.uk/petitions/269586
18.191.46.36 Thu, 25 Apr 2024 01:39:59 +0100
